TW271442B - - Google Patents

Info

Publication number
TW271442B
TW271442B TW082104717A TW82104717A TW271442B TW 271442 B TW271442 B TW 271442B TW 082104717 A TW082104717 A TW 082104717A TW 82104717 A TW82104717 A TW 82104717A TW 271442 B TW271442 B TW 271442B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
calcium channels
cells
Prior art date
Application number
TW082104717A
Other languages
English (en)
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Application granted granted Critical
Publication of TW271442B publication Critical patent/TW271442B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
TW082104717A 1992-07-27 1993-06-14 TW271442B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91953892A 1992-07-27 1992-07-27

Publications (1)

Publication Number Publication Date
TW271442B true TW271442B (zh) 1996-03-01

Family

ID=25442279

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082104717A TW271442B (zh) 1992-07-27 1993-06-14

Country Status (28)

Country Link
US (1) US5599559A (zh)
EP (1) EP0656905B1 (zh)
JP (1) JP2571197B2 (zh)
KR (1) KR950702577A (zh)
CN (1) CN1086824A (zh)
AT (1) ATE157672T1 (zh)
AU (1) AU662066B2 (zh)
BR (1) BR9306796A (zh)
CA (1) CA2139947C (zh)
CZ (1) CZ281539B6 (zh)
DE (1) DE69313650T2 (zh)
DK (1) DK0656905T3 (zh)
ES (1) ES2105284T3 (zh)
FI (1) FI933349A (zh)
GR (1) GR3024637T3 (zh)
HR (1) HRP931050B1 (zh)
HU (1) HU213353B (zh)
IL (1) IL106424A0 (zh)
MX (1) MX9304497A (zh)
MY (1) MY131356A (zh)
NZ (1) NZ253611A (zh)
PL (1) PL307258A1 (zh)
RU (1) RU2104286C1 (zh)
SK (1) SK10395A3 (zh)
TW (1) TW271442B (zh)
WO (1) WO1994002511A1 (zh)
YU (1) YU51593A (zh)
ZA (1) ZA935370B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387696B1 (en) 1988-04-04 2002-05-14 Merck & Co., Inc. Human calcium channel compositions and methods
US5846757A (en) * 1988-04-04 1998-12-08 Sibia Neurosciences, Inc. Human calcium channel α1, α2, and β subunits and assays using them
US5876958A (en) * 1988-04-04 1999-03-02 Sibia Neurosciences, Inc. Assays of cells expressing human calcium channels containing α1 β subunits
US6653097B1 (en) 1991-08-15 2003-11-25 Merck & Co., Inc. Human calcium channel compositions and methods
US5407820A (en) * 1988-04-04 1995-04-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Calcium channel α-2 subunit DNAs and cells expressing them
CA1341170C (en) * 1988-04-04 2001-01-16 Steven B. Ellis Calcium channel compositions and methods
US20040018510A1 (en) 1990-11-08 2004-01-29 Merck & Co., Inc. Human calcium channel compositions and methods
US6096514A (en) * 1988-04-04 2000-08-01 Sibia Neurosciences, Inc. Human calcium channel compositions and methods
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US6090623A (en) * 1993-08-11 2000-07-18 Merck & Co., Inc. Recombinant human calcium channel β4 subunits
ES2075796B1 (es) * 1993-08-17 1996-03-01 Pfizer Polipeptido de la agelenopsis aperta bloqueante de los canales de ca lcio
AU7142996A (en) 1995-09-29 1997-04-28 Universita' Degli Studi Di Siena Regulated genes and uses thereof
DK1749836T3 (da) 1996-08-23 2009-08-31 Vegenics Ltd Rekombinant vaskulær endothelcellevækstfaktor D
US6528630B1 (en) 1997-12-03 2003-03-04 Merck & Co., Inc. Calcium channel compositions and methods
ES2552639T3 (es) * 1998-07-10 2015-12-01 Novartis Pharma Ag Uso combinado de valsartán y bloqueantes de los canales de calcio para fines terapéuticos
US8299211B2 (en) * 2005-09-30 2012-10-30 The Board Of Trustees Of The University Of Illinois Peptides and regulation of calcium channels
CN103768469A (zh) * 2012-10-23 2014-05-07 葛继云 一种治疗妇科炎症的中药组合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064657A (en) * 1986-10-20 1991-11-12 University Of Utah Spider toxins and methods for their use as blockers of amino acid receptor function
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
US5196204A (en) * 1986-10-20 1993-03-23 University Of Utah Research Foundation Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
US5122596A (en) * 1989-09-29 1992-06-16 Pfizer Inc. Polypeptides useful as blockers of calcium channels

Also Published As

Publication number Publication date
AU662066B2 (en) 1995-08-17
FI933349A0 (fi) 1993-07-26
JP2571197B2 (ja) 1997-01-16
RU2104286C1 (ru) 1998-02-10
CZ281539B6 (cs) 1996-10-16
KR950702577A (ko) 1995-07-29
HRP931050B1 (en) 1999-04-30
DE69313650T2 (de) 1998-01-08
NZ253611A (en) 1996-09-25
WO1994002511A1 (en) 1994-02-03
MX9304497A (es) 1994-04-29
RU95105340A (ru) 1996-10-27
IL106424A0 (en) 1993-11-15
DE69313650D1 (en) 1997-10-09
PL307258A1 (en) 1995-05-15
FI933349A (fi) 1994-01-28
ZA935370B (en) 1995-01-26
YU51593A (sh) 1997-01-08
ATE157672T1 (de) 1997-09-15
ES2105284T3 (es) 1997-10-16
EP0656905B1 (en) 1997-09-03
CZ9500200A3 (en) 1995-10-18
CA2139947C (en) 1998-06-30
AU4407893A (en) 1994-02-14
CN1086824A (zh) 1994-05-18
HRP931050A2 (en) 1996-12-31
HU213353B (en) 1997-05-28
MY131356A (en) 2007-08-30
JPH07504685A (ja) 1995-05-25
CA2139947A1 (en) 1994-02-03
HUT67467A (en) 1995-04-28
GR3024637T3 (en) 1997-12-31
SK10395A3 (en) 1995-06-07
EP0656905A1 (en) 1995-06-14
BR9306796A (pt) 1998-12-08
DK0656905T3 (da) 1997-10-20
US5599559A (en) 1997-02-04
HU9302158D0 (en) 1993-11-29

Similar Documents

Publication Publication Date Title
TW271442B (zh)
EG20275A (en) Calcium channel blacking polypeptides from filistato hibernalis
CZ112695A3 (en) Polypeptide and use thereof
NO950293L (no) Kalsiumkanalblokkerende polypeptid fra Agelenopsis aperta
ES2075796A1 (es) Polipeptido de la agelenopsis aperta bloqueante de los canales de ca lcio